Author

Tahani Alramah

Observed name: Alramah, Tahani Y.M.

Institution: Dasman Diabetes Institute

Observed institution: Dasman Diabetes Institute

ORCID: 0000-0003-4850-6505

Observed ORCID: 0000-0003-4850-6505

OpenAlex ID: A5063486409

Adolescent obesity and ANGPTL8: correlations with high sensitivity C-reactive protein, leptin, and chemerin

2023 · Maha M. Hammad, Arshad M. Channanath, et al. · Frontiers in Endocrinology · 11

Circulating Isthmin-1 Levels and Their Relationship with Diabetes and Metabolic Diseases in Kuwaiti Adults

2025 · Eman Alshawaf, Sulaiman K. Marafie, et al. · Biomedicines · 10

Evaluating the correlation of sclerostin levels with obesity and type 2 diabetes in a multiethnic population living in Kuwait

2024 · Tahani Alramah, Preethi Cherian, et al. · Frontiers in Endocrinology · 8

Novel metabolic risk markers in obesity and type two Diabetes mellitus

2020 · Alramah, Tahani Y.M. · Enlighten: Theses (The University of Glasgow) · 1

Ethnic Variations in the Levels of Bone Biomarkers (Osteoprostegerin, Receptor Activator of Nuclear Factor Kappa-Β Ligand and Glycoprotein Non-Metastatic Melanoma Protein B) in People with Type 2 Diabetes

2024 · Preethi Cherian, Irina Al-Khairi, et al. · Biomedicines

Associations of targeted circulating microRNAs with insulin resistance in the CAMERA (Carotid Atherosclerosis: MEtformin for insulin ResistAnce) trial

2019 · Tahani Alramah, David Preiss, et al. · Diabetic Medicine

Putative miRNA biomarkers of insulin resistance and the effect of metformin: data from the CAMERA trial

2017 · Tahani Alramah, Karine Pinel, et al. · Diabetologia

Works count: 7

Citation count: 30

H-index: 3

I10-index: 2